Yoga Efficacy and Bioactive Materials in the Blood of Korean Elderly

April 26, 2022 updated by: Wonryeon Cho

The Studies of Yoga Efficacy and Bioactive Materials in the Blood of Korean Elderly

This study is conducted to verify the relationships between yoga efficacy and bioactive materials in the blood of Korean elderly.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Glycoproteomics approach will be applied to verify the relationships between yoga efficacy and bioactive materials in the blood of Korean elderly.

Study Type

Interventional

Enrollment (Anticipated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Byungsoo Yu, PhD
  • Phone Number: 821096541429
  • Email: ybs@wku.ac.kr

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • The elderly group participant over 60 years old.
  • The young group participant over 20 to 57 years old.
  • Individual who can read and understand Korean.
  • Participant is willing and able to give informed consent for participation in the study.

Exclusion Criteria:

  • Participant who was diagnosed with cancer in the last five years.
  • In case of participants leaving the yoga program after the primary blood collecting, they will be excluded from the secondary blood collecting.
  • Individuals who are judged inappropriate for the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Yoga participant groups
Yoga participant groups will practice elderly yoga for four months. We will collect their blood before and after their participation in the elderly yoga program. There will be two subgroups which are Advanced group and Beginner group.
Behavioral: Participation in the elderly yoga program
Yoga participant groups will practice elderly yoga for four months.
No Intervention: Non-Yoga participant groups
Non-Yoga participant groups will not practice yoga for four months and will be used as the control. We will collect their blood before and after the elderly yoga program. There will be two subgroups which are Elderly group and Young group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measuring the number of glycoproteins in blood between before and after participation in an elderly yoga program for both the Advanced group and Beginner group
Time Frame: 4 months

Glycoproteins in human plasma are known to be deeply associated with multiple diseases, cell differentiation, aging, and etc.

The efficacy of elderly yoga will be assessed by identifying and comparing the number of glycoproteins in blood between before and after participation in an elderly yoga program for both the Advanced group and Beginner group.
4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Wonryeon Cho

Investigators

  • Principal Investigator: Wonryeon Cho, PhD, Wonkwang University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 23, 2015

Primary Completion (Anticipated)

August 31, 2022

Study Completion (Anticipated)

February 28, 2023

Study Registration Dates

First Submitted

September 23, 2018

First Submitted That Met QC Criteria

September 27, 2018

First Posted (Actual)

October 1, 2018

Study Record Updates

Last Update Posted (Actual)

April 27, 2022

Last Update Submitted That Met QC Criteria

April 26, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • WonkwangU

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Elderly

Clinical Trials on Participation in the elderly yoga program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe